Department Of Urology
Investigator
Joel DeCastro, MD, MPH
Phone
212-932-4309
Email
gjd16@cumc.columbia.edu
G. Joel DeCastro, MD, MPH, an Assistant Professor of Urology at Columbia University Medical Center. Dr. DeCastro graduated with cum laude honors in Biology from Harvard University in 1997. He then went on to complete his medical school training, a Masters in Public Health, and his Urology residency at Columbia University Medical Center in New York. After residency, he completed a two-year fellowship in Urologic Oncology at the University of Chicago, focused on laparoscopic and robotic surgery. He serves on the review panel of numerous publications, including the Journal of Urology and the Journal of Endourology. He has authored multiple original research articles, book chapters, and editorials on urologic oncology. His present research is primarily on outcomes following treatment for bladder cancer.

Dr. DeCastro is an established expert in both robotic and laparoscopic techniques for treatment of urologic tumors, specifically for bladder, kidney, prostate, and testicular cancer. He sees patients both at the Allen Hospital and at the Herbert Irving Pavillion on the main hospital campus, and participates in most insurance plans.

Clinical Studies Managed By This Investigator:
Condition Study Title
Urology [ CLOSED ] A study for patients with bladder cancer using the Cysview and blue light system to detect tumors in order to prevent reoccurence
Cancer [ CLOSED ] A study for patients with bladder cancer using study drug Vincinum
Bladder Cancer [ CLOSED ] nab-Rapamycin Treatment for BCG Refractory Bladder Cancer
Bladder Cancer [ CLOSED ] Study of Multidrug Treatment in Patients with Muscle-Invasive Bladder Cancer
Bladder Cancer [ CLOSED ] MdxHealth: Study of Urine Samples in Patients with Hematuria (Blood in Urine)
Bladder Cancer [ CLOSED ] Study of New Treatment for Non-Muscle-Invasive Bladder Cancer
Prostate Cancer [ CLOSED ] Testing Computer Tools to Improve Prostate Cancer Decisions
Bladder Cancer [ CLOSED ] Study of NanoDoce Injection and as Fluid Inserted in Bladder in Subjects with Bladder Cancer
Bladder Cancer [ CLOSED ] Study of Intravesical Cabazitaxel, Gemcitabine and Cisplatin (CGC) in the Treatment of Urothelial Carcinoma (Bladder Cancer)
Bladder Cancer [ CLOSED ] First-in-Human Study of PF-07225570 Alone or in Combination with Sasanlimab for Patients with Non-Muscle Invasive Bladder Cancer (NMIBC)